Maravai LifeSciences
(NASDAQ) MRVI
Maravai LifeSciences Financials at a Glance
Market Cap
$792.11M
Revenue (TTM)
$204.73M
Net Income (TTM)
-$104.56M
EPS (TTM)
-$0.72
P/E Ratio
-7.43
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$5.38
Volume
1,138,515.859
Open
$5.25
Price
$5.38
Volume
1,138,515.859
Open
$5.25
Previous Close
$5.37
Daily Range
$5.23 - $5.42
52-Week Range
$1.99 - $5.42
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
1.12 (Average)
Price
$5.38
Volume
1,138,515.859
Open
$5.25
Previous Close
$5.37
Daily Range
$5.23 - $5.42
52-Week Range
$1.99 - $5.42
Estimated Earnings Date
Aug 11, 2026
MRVI News
MRVI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Maravai LifeSciences
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
435
CEO
Bernd Brust
Website
www.maravai.comHeadquarters
San Diego, CA 92121, US
MRVI Financials
Key Financial Metrics (TTM)
Gross Margin
29.00%
Operating Margin
21.93%
Net Income Margin
-51.07%
Return on Equity
-44.72%
Return on Capital
-2.72%
Return on Assets
-14.66%
Earnings Yield
-13.46%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$792.11M
Shares Outstanding
147.51M
Volume
1.14M
Avg. Volume
2.48M
Financials (TTM)
Gross Profit
$59.37M
Operating Income
$44.90M
EBITDA
-$103.91M
Operating Cash Flow
-$39.52M
Capital Expenditure
-$12.35M
Free Cash Flow
-$51.87M
Cash & ST Invst.
$165.92M
Total Debt
$270.88M
Maravai LifeSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$65.84M
+40.5%
Gross Profit
$33.70M
+336.3%
Gross Margin
51.19%
N/A
Market Cap
$792.11M
N/A
Market Cap/Employee
$1.39M
N/A
Employees
570
N/A
Net Income
-$3.73M
+87.5%
EBITDA
$12.20M
+139.3%
Quarterly Fundamentals
Total Cash
$165.92M
-41.8%
Total Debt
$270.88M
-17.1%
Accounts Receivable
$33.42M
+17.3%
Inventory
$40.46M
-18.7%
Long Term Debt
$265.44M
-17.1%
Short Term Debt
$5.44M
-13.3%
Return on Assets
-14.66%
N/A
Return on Invested Capital
6.70%
N/A
Free Cash Flow
$4.23M
+128.9%
Operating Cash Flow
$8.67M
+192.3%